Log in to save to my catalogue

Gastric Cancer Risk and Pathogenesis in IBRCA1/I and IBRCA2/I Carriers

Gastric Cancer Risk and Pathogenesis in IBRCA1/I and IBRCA2/I Carriers

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracacademiconefile_A745273532

Gastric Cancer Risk and Pathogenesis in IBRCA1/I and IBRCA2/I Carriers

About this item

Full title

Gastric Cancer Risk and Pathogenesis in IBRCA1/I and IBRCA2/I Carriers

Publisher

MDPI AG

Journal title

Cancers, 2022-12, Vol.14 (23)

Language

English

Formats

Publication information

Publisher

MDPI AG

More information

Scope and Contents

Contents

Germline BRCA1 and BRCA2 pathogenic variant carriers are recognized to be at increased risk for multiple cancers including breast, ovarian, pancreatic, and prostate cancer, with risk management recommendations for these cancers included in BRCA1/2 guidelines. Currently, it is remains uncertain whether BRCA1/2 carriers are also at an increased risk...

Alternative Titles

Full title

Gastric Cancer Risk and Pathogenesis in IBRCA1/I and IBRCA2/I Carriers

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracacademiconefile_A745273532

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracacademiconefile_A745273532

Other Identifiers

ISSN

2072-6694

E-ISSN

2072-6694

DOI

10.3390/cancers14235953

How to access this item